Diagnostics
ERT Announces New Report by TUFTS Identifying Growth in Adoption of Centralized ECG Services
June 21, 2010 6:34 am | by RealWire | News | CommentsPHILADELPHIA, 21 June 2010 - ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, announced today the availability of a new report, conducted by the Tufts Center for the Study of Drug Development, mapping the growing...
CardioGenics Selects Clinical Test Sites for Its High Speed Portable Blood Analyzer
June 21, 2010 6:33 am | by Bio-Medicine.Org | News | CommentsMISSISSAUGA, Ontario , June 21 /- CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH), developer of the ultra-sensitive QL Careâ„¢ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced the selection of four sites for...
Coffee May Protect Against Head and Neck Cancers
June 18, 2010 4:34 pm | by AACR | News | CommentsThe embargo has been lifted on the AACR press release: “Coffee May Protect Against Head and Neck Cancers,†due to a violation by Drug Discovery and Development and the Sci-Tech Heretic blog. Reporters may post their stories effective immediately. • Caffeinated coffee protected against...
Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2010
June 18, 2010 8:33 am | by Bio-Medicine.Org | News | CommentsROCKVILLE, Md. , June 18 /- Novavax, Inc. (Nasdaq: NVAX ) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi , President and Chief Executive Officer, will be presenting at the Phacilitate Vaccine Forum Barcelona 2010 conference on June 21 and June 22, 2010 at The...
Vitamin D deficiency confirmed as common across a range of rheumatic conditions
June 18, 2010 4:33 am | by EurekAlert | News | Comments(European League Against Rheumatism) Two separate studies have shown that vitamin D deficiency is common in patients with a range of rheumatic diseases, with over half of all patients having below the "normal" healthy levels of vitamin D (48-145 nmol/L) in their bodies. A further...
TGen partner, PBS-Bio, makes first breakthrough drug analysis
June 18, 2010 12:33 am | by EurekAlert | News | Comments(The Translational Genomics Research Institute) Predictive Biomarker Sciences Inc. has completed its first drug analysis, enabling Canadian biotech company PharmaGap Inc. to significantly advance a potentially significant anti-cancer medication.
Women who consume large amounts of tea have increased risk of rheumatoid arthritis
June 18, 2010 12:33 am | by EurekAlert | News | Comments(European League Against Rheumatism) Women who drink tea have an increased risk of developing rheumatoid arthritis (RA) compared with those who drink none (p=0.04), according to results presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in...
Partners grieve rheumatoid arthritis diagnosis as much as patients
June 18, 2010 12:33 am | by EurekAlert | News | Comments(European League Against Rheumatism) Partners of patients newly diagnosed with rheumatoid arthritis are equally emotionally affected by the diagnosis and go through the same grieving process as the patients themselves, according to the results of a study presented today at EULAR...
Brainlab Collaborates With Toshiba Medical Systems on Integrated Surgical Suite
June 17, 2010 10:33 am | by Bio-Medicine.Org | News | CommentsMUNICH , June 17 /- Brainlab AG today announced that it has signed an agreement with Toshiba Medical Systems Corporation, Inc., a business unit of the Toshiba Group, to integrate its Aquilion™ LB Computed Tomography (CT) scanner with the Brainlab Brainsuite® iCT digitally...
Copan Redefines Automated Specimen Processing with Groundbreaking New Features
June 17, 2010 10:33 am | by Bio-Medicine.Org | News | CommentsMURRIETA, Calif. , June 17 /- Copan unveiled new groundbreaking features of its Walk-Away Specimen Processor (WASP) while attending the 110th General Meeting for the American Society for Microbiology (ASM) in San Diego, California this past May. Copan's line of automation was...
Omnicell's Automated Medication Dispensing System Honored With 2010 Best in KLAS Award
June 17, 2010 10:32 am | by Bio-Medicine.Org | News | CommentsMOUNTAIN VIEW, Calif. , June 17 /- Omnicell, Inc. (Nasdaq: OMCL ), a leading provider of system solutions to acute healthcare facilities, today announced that KLAS, a prestigious healthcare research firm, has named Omnicell's OmniRx® automated dispensing system the recipient of its...
Abbott lays off 120 from California stents operation
June 17, 2010 6:33 am | by Mass Device | News | CommentsAbbott Laboratories lays off 120 workers in California, the majority of whom worked in the company's stent manufacturing operation there. Abbott Laboratories (NYSE:ABT) laid off 120 workers from its California stent-making operation. The Abbott Park, Ill.-based company...
Diagnostic Imaging Markets in Brazil, Russia, India, China (BRIC) 2010 - 2015: MarketsandMarkets
June 17, 2010 5:33 am | by Bio-Medicine.Org | News | CommentsDALLAS , June 17, 2010 /- The Medical Device practice at MarketsandMarkets is pleased to announce a new report titled Diagnostic Imaging Markets in Brazil , Russia , India , China (BRIC) 2010 - 2015. Browse in-depth TOC on Diagnostic Imaging Markets in Brazil , Russia , India , China...
Predictive Biosciences Closes $25 million Series C round
June 16, 2010 6:37 am | by Mass Device | News | CommentsPredictive Biosciences plans to use its now-completed $25 million Series C round to begin commercializing its biomarker-based bladder cancer test. Predictive Biosciences completed a $25 million Series C round, saying it plans to use the money to complete clinical trials for its...
Little is understood about alcohol's effect on fetal development, Georgetown researchers say
June 15, 2010 8:38 pm | by EurekAlert | News | Comments(Georgetown University Medical Center) It's long been known that alcohol use in pregnancy can lead to children with mental retardation and birth defects, but researchers who study fetal alcohol syndrome have not made definitive progress on preventing the disorder, detecting it...
Combined BRAF-targeted and Immunotherapy Shows Promise for Melanoma Treatment
June 15, 2010 10:37 am | by AACR | News | Comments• Oncogenic BRAF contributes to immune escape in melanoma. • MAPK pathway inhibition can release suppression. • BRAF inhibition improves T-cell immune response against cancer. PHILADELPHIA - Combined targeted therapy against the BRAF/MAPK pathway with immunotherapy shows promise as a new...
BRAF Inhibitor Shows Promising Preclinical Activity Against Melanoma
June 15, 2010 10:37 am | by AACR | News | Comments• Phase III trial currently enrolling • Clear tumor regression seen in preclinical models • No increased toxicity observed PHILADELPHIA - Preclinical findings recently published in Cancer Research, a journal of the American Association for Cancer Research, showed RG7204 (PLX4032)...
Epocal Announces FDA Clearance of Lactate Test
June 15, 2010 6:38 am | by Bio-Medicine.Org | News | CommentsOTTAWA, Canada , June 15 /- Epocal, Inc., a leading edge provider of point of care technology, announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market its new lactate test on the epoc Blood Analysis System. Lactate measurements from the epoc...
Dominion Diagnostics Introduces CARDâ„¢: The Next-Generation Clinical Laboratory Diagnostics Tool for Addiction Treatment
June 15, 2010 6:37 am | by Bio-Medicine.Org | News | CommentsNORTH KINGSTOWN, R.I. , June 15 /- At the forefront of the ongoing effort to enhance addiction treatment outcomes, one leading Rhode Island Company has announced the next-generation clinical laboratory diagnostics tool designed to assist clinicians. Â Dominion Diagnostics (Dominion),...
Adeona Announces HartLab Expansion Into Microbiology Testing Services
June 15, 2010 3:38 am | by Bio-Medicine.Org | News | CommentsANN ARBOR, Mich. , June 15 /- Adeona Pharmaceuticals, Inc. (Amex: AEN ) announced that its wholly-owned CLIA-certified clinical testing subsidiary, HartLab, has expanded its in-house diagnostic testing services to include a full array of microbiology testing. Adeona believes that...
CT angiography may be unnecessary in patients with suspected pulmonary embolism
June 14, 2010 9:37 pm | by EurekAlert | News | Comments(Radiological Society of North America) A new study suggests that computed tomography (CT) angiography might be unnecessary in many patients suspected of having pulmonary embolism (PE), based on the results of risk assessment analysis. PE risk assessment could help reduce radiation...
The MassDevice Weekly Checkup: June 15, 2010
June 14, 2010 4:37 pm | by Mass Device | News | CommentsTaking the financial temperature of the medical devices industry. Our Weekly Checkup takes the temperature of the medical device industry's three largest U.S. clusters: Massachusetts, California and Minnesota. The MassDevice Indices are weighted according to market...
Consumer Information on: Photodynamic Diagnostic D-Light C (PDD) System - P050027
June 14, 2010 9:38 am | by U.S. Food & Drug Administration | News | CommentsThe Karl Storz Photodynamic Diagnostic D-Light C (PDD) System is used as an optional accessory to white light cystoscopy when used in combination with the diagnostic imaging drug Cysview® (Photocure ASA, a Norwegian pharmaceutical company).
Prostate Cancer: The Father's Day Gift You Never Thought About
June 14, 2010 9:38 am | by Bio-Medicine.Org | News | CommentsMARLTON, N.J. , June 14 /- While Father's Day gifts range from the touching to the hilarious, the best gift you might give your father or spouse is help and support during the difficult time of a cancer diagnosis. Often men have tremendous difficulties deciding about their treatment,...
Medical device makers drop $20 million on D.C. lobbying
June 14, 2010 9:38 am | by Mass Device | News | CommentsThe medical device industry spent at least $20 million to lobby lawmakers and federal agencies during the first quarter. The medical device industry once again spent big bucks to ensure its voice was heard in Washington during the first quarter, dropping more than $20 million...
